{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "S protein",
      "neutralizing antibodies",
      "two proline substitutions",
      "vaccines"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33853488",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "09",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "04",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1080/14760584.2021.1918003"
    ],
    "Journal": {
      "ISSN": "1744-8395",
      "JournalIssue": {
        "Volume": "20",
        "Issue": "7",
        "PubDate": {
          "Year": "2021",
          "Month": "Jul"
        }
      },
      "Title": "Expert review of vaccines",
      "ISOAbbreviation": "Expert Rev Vaccines"
    },
    "ArticleTitle": "Progress in research on the S protein as the target of COVID-19 vaccines.",
    "Pagination": {
      "StartPage": "769",
      "EndPage": "772",
      "MedlinePgn": "769-772"
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-1682-5547"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China."
          }
        ],
        "LastName": "Abdalla",
        "ForeName": "Mohnad",
        "Initials": "M"
      },
      {
        "Identifier": [
          "0000-0003-0420-7191"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt."
          }
        ],
        "LastName": "El-Arabey",
        "ForeName": "Amr Ahmed",
        "Initials": "AA"
      },
      {
        "Identifier": [
          "0000-0003-0074-6876"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China."
          }
        ],
        "LastName": "Jiang",
        "ForeName": "Xinyi",
        "Initials": "X"
      }
    ],
    "PublicationTypeList": [
      "Editorial",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Expert Rev Vaccines",
    "NlmUniqueID": "101155475",
    "ISSNLinking": "1476-0584"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "trends"
      ],
      "DescriptorName": "Biomedical Research"
    },
    {
      "QualifierName": [
        "metabolism",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "metabolism"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [
        "trends"
      ],
      "DescriptorName": "Drug Delivery Systems"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "metabolism"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    }
  ]
}